146 related articles for article (PubMed ID: 16612664)
1. Multiple evidence for an early age pro-oxidant state in Down Syndrome patients.
Pallardó FV; Degan P; d'Ischia M; Kelly FJ; Zatterale A; Calzone R; Castello G; Fernandez-Delgado R; Dunster C; Lloret A; Manini P; Pisanti MA; Vuttariello E; Pagano G
Biogerontology; 2006 Aug; 7(4):211-20. PubMed ID: 16612664
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases.
Lloret A; Calzone R; Dunster C; Manini P; d'Ischia M; Degan P; Kelly FJ; Pallardó FV; Zatterale A; Pagano G
Free Radic Biol Med; 2008 Feb; 44(4):495-503. PubMed ID: 18053816
[TBL] [Abstract][Full Text] [Related]
3. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.
Pagano G; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Zatterale A; Anak SS; Akisik EE; Beneduce G; Calzone R; De Nicola E; Dunster C; Lloret A; Manini P; Nobili B; Saviano A; Vuttariello E; Warnau M
Carcinogenesis; 2004 Oct; 25(10):1899-909. PubMed ID: 15192013
[TBL] [Abstract][Full Text] [Related]
4. Glutathione levels in blood from ataxia telangiectasia patients suggest in vivo adaptive mechanisms to oxidative stress.
Degan P; d'Ischia M; Pallardó FV; Zatterale A; Brusco A; Calzone R; Cavalieri S; Kavakli K; Lloret A; Manini P; Pisanti MA; Vuttariello E; Pagano G
Clin Biochem; 2007 Jun; 40(9-10):666-70. PubMed ID: 17466964
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress biomarkers in four Bloom syndrome (BS) patients and in their parents suggest in vivo redox abnormalities in BS phenotype.
Zatterale A; Kelly FJ; Degan P; d'Ischia M; Pallardó FV; Calzone R; Dunster C; Lloret A; Manini P; Coğulu O; Kavakli K; Pagano G
Clin Biochem; 2007 Oct; 40(15):1100-3. PubMed ID: 17678887
[TBL] [Abstract][Full Text] [Related]
6. Increased oxidative stress biomarkers in the saliva of Down syndrome patients.
Komatsu T; Duckyoung Y; Ito A; Kurosawa K; Maehata Y; Kubodera T; Ikeda M; Lee MC
Arch Oral Biol; 2013 Sep; 58(9):1246-50. PubMed ID: 23714170
[TBL] [Abstract][Full Text] [Related]
7. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Zitnanová I; Korytár P; Aruoma OI; Sustrová M; Garaiová I; Muchová J; Kalnovicová T; Pueschel S; Duracková Z
Clin Chim Acta; 2004 Mar; 341(1-2):139-46. PubMed ID: 14967170
[TBL] [Abstract][Full Text] [Related]
8. Systemic oxidative stress in children and teenagers with Down syndrome.
Garlet TR; Parisotto EB; de Medeiros Gda S; Pereira LC; Moreira EA; Dalmarco EM; Dalmarco JB; Wilhelm Filho D
Life Sci; 2013 Oct; 93(16):558-63. PubMed ID: 24004546
[TBL] [Abstract][Full Text] [Related]
9. In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes.
Pagano G; Zatterale A; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Calzone R; Castello G; Dunster C; Giudice A; Kilinç Y; Lloret A; Manini P; Masella R; Vuttariello E; Warnau M
Free Radic Res; 2005 May; 39(5):529-33. PubMed ID: 16036329
[TBL] [Abstract][Full Text] [Related]
10. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
Mehta PD; Capone G; Jewell A; Freedland RL
J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
[TBL] [Abstract][Full Text] [Related]
11. Plasma nerve growth factor (NGF) and inflammatory cytokines (IL-6 and MCP-1) in young and adult subjects with Down syndrome: an interesting pathway.
Corsi MM; Dogliotti G; Pedroni F; Palazzi E; Magni P; Chiappelli M; Licastro F
Neuro Endocrinol Lett; 2006 Dec; 27(6):773-8. PubMed ID: 17187019
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
[TBL] [Abstract][Full Text] [Related]
13. Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender.
Cavalca V; Veglia F; Squellerio I; Marenzi G; Minardi F; De Metrio M; Cighetti G; Boccotti L; Ravagnani P; Tremoli E
Eur J Clin Invest; 2009 Apr; 39(4):267-72. PubMed ID: 19292881
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and oxidative stress in Egyptian children with Down syndrome.
Meguid NA; Dardir AA; El-Sayed EM; Ahmed HH; Hashish AF; Ezzat A
Clin Biochem; 2010 Aug; 43(12):963-7. PubMed ID: 20450901
[TBL] [Abstract][Full Text] [Related]
15. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes.
Gil L; Siems W; Mazurek B; Gross J; Schroeder P; Voss P; Grune T
Free Radic Res; 2006 May; 40(5):495-505. PubMed ID: 16551576
[TBL] [Abstract][Full Text] [Related]
16. Urinary uric acid and antioxidant capacity in children and adults with Down syndrome.
Campos C; Guzmán R; López-Fernández E; Casado A
Clin Biochem; 2010 Feb; 43(3):228-33. PubMed ID: 19786004
[TBL] [Abstract][Full Text] [Related]
17. Altered vessel signalling molecules in subjects with Downs syndrome.
Licastro F; Chiappelli M; Porcellini E; Trabucchi M; Marocchi A; Corsi MM
Int J Immunopathol Pharmacol; 2006; 19(1):181-5. PubMed ID: 16569356
[TBL] [Abstract][Full Text] [Related]
18. Vitamin C and E combination modulates oxidative stress induced by X-ray in blood of smoker and nonsmoker radiology technicians.
Kayan M; Naziroğlu M; Celik O; Yalman K; Köylü H
Cell Biochem Funct; 2009 Oct; 27(7):424-9. PubMed ID: 19637207
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant system in Down syndrome: a possible role in cataractogenesis.
Cengiz M; Seven M; Suyugül N
Genet Couns; 2002; 13(3):339-42. PubMed ID: 12416643
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia.
Pfeifer WP; Degasperi GR; Almeida MT; Vercesi AE; Costa FF; Saad ST
Acta Haematol; 2008; 120(4):225-31. PubMed ID: 19218790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
